Author

B. Olson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:DNA methylation· 2 Organism:mouse· 2 Assay:whole-genome sequencing· 2 Research Focus:cell-cell communication· 1

Frequent Co-Authors

A. Dowdye· 1 shared A. J. Herr· 1 shared A. K. Tewari· 1 shared A. L. Damon· 1 shared A. Patnaik· 1 shared A. T. M. Cheung· 1 shared A. Thomas· 1 shared B. S. Thomas· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Dowdye

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

BET inhibition sensitizes immunologically-cold Rb-deficient prostate cancer to immune checkpoint blockade

B. Olson, K. Chaudagar, R. Bao, S. Sharma-Saha, C. Hong, S. Rameshbabu, R. Chen, A. Thomas, A. Patnaik

This paper shows that BET inhibition makes immunologically cold Rb-deficient prostate cancer more responsive to immune checkpoint blockade by reprogramming the tumor microenvironment through STING/NF-κB/IFN signaling.

bioRxiv · Mar 24, 2022Cancer Biology

A patient-driven clinicogenomic partnership through the Metastatic Prostate Cancer Project

J. Crowdis, S. Balch, L. Sterlin, B. S. Thomas, S. Y. Camp, M. Dunphy, E. Anastasio, S. Shah, A. L. Damon, R. Ramos, D. M. Sosa, I. K. Small, B. Tomson, C. M. Nguyen, M. McGillicuddy, , E. M. Van Allen

The paper describes a patient-driven initiative that collects clinicogenomic data from metastatic prostate cancer patients, revealing consistent patient-reported data and genomic insights from cfDNA samples.

bioRxiv · Jul 9, 2021 · PreprintCancer Biology

Rate volatility and asymmetric segregation diversify mutation burden in mutator cells.

I. T. Dowsett, J. Sneeden, B. Olson, J. Mckay-Fleisch, E. McAuley, S. R. Kennedy, A. J. Herr

The paper models how mutator phenotypes in budding yeast increase genetic heterogeneity through rate volatility and asymmetric mutation segregation.

bioRxiv · Jun 21, 2020Cancer Biology

A distinct neutrophil population invades the central nervous system during pancreatic cancer

K. G. Burfeind, X. Zhu, M. A. Norgard, P. R. Levasseur, B. Olson, K. A. Michaelis, E. R. S. Torres, S. Jeng, S. McWeeney, J. Raber, D. L. Marks

This study identifies a novel neutrophil population invading the brain during pancreatic cancer, mediated by CCR2/CCL2 and P2RX7, leading to anorexia and muscle catabolism.

bioRxiv · Jun 3, 2019 · PreprintImmunology